Hirschsprung disease (HD)

Etiology and Pathophysiology

Etiology: Hirschsprung disease (HD) is a congenital condition resulting from the failure of neural crest cells to migrate completely during intestinal development. This leads to an absence of ganglion cells (aganglionosis) in the myenteric (Auerbach) and submucosal (Meissner) plexuses of the intestine. The primary genetic cause is mutations in the RET proto-oncogene, but other genes such as EDNRB, EDN3, and GDNF also contribute to its pathogenesis.

Pathophysiology: In HD, the aganglionic segment of the colon fails to relax, causing functional obstruction. The absence of ganglion cells leads to sustained contraction of the affected bowel segment. This results in a blockage of fecal movement and subsequent proximal bowel dilation and hypertrophy. The main pathophysiological changes include:

• Lack of peristalsis in the aganglionic segment.
• Functional obstruction and subsequent proximal colonic dilatation (megacolon).
• Increased intraluminal pressure and risk of enterocolitis.

Types of Hirschsprung Disease

Based on Extent of Aganglionosis:

1. Short-Segment HD: Involvement of the rectum and a short portion of the sigmoid colon. This is the most common form.
2. Long-Segment HD: Aganglionosis extends beyond the sigmoid colon.
3. Total Colonic Aganglionosis: The entire colon is affected.
4. Ultra-Short Segment HD: Very short segment of aganglionosis confined to the rectum.

Clinical Presentation and Diagnosis

Clinical Presentation:

• Newborns: Failure to pass meconium within the first 48 hours of life, vomiting, abdominal distension, and reluctance to feed.
• Infants and Older Children: Chronic constipation, abdominal distension, failure to thrive, and episodes of enterocolitis (fever, diarrhea, and abdominal distension).

Physical Examination:

• Abdominal distension and tenderness.
• Rectal examination may reveal a tight anal canal and an explosive release of stool and gas upon withdrawal of the examining finger (blast sign).

---

Diagnostic Tests

1. Calretinin Test

Calretinin is a calcium-binding protein used as an immunohistochemical marker to differentiate aganglionic from normally innervated bowel segments.

Procedure:

• Biopsy: A rectal biopsy sample is obtained from the patient.
• Staining: The biopsy sample is stained for calretinin.

Interpretation:

• Normal Innervation: Positive calretinin staining is observed in the nerve fibers of the submucosa and muscularis propria, indicating the presence of ganglion cells.
• Aganglionic Segment: Absence of calretinin staining indicates a lack of ganglion cells, which is characteristic of Hirschsprung disease.

2. Rectal Suction Biopsy

Rectal suction biopsy is the gold standard for diagnosing Hirschsprung disease.

Procedure:

• A small sample of mucosa and submucosa is taken from the rectum using a suction device.

Findings:

• Normal Tissue: Presence of ganglion cells and normal-sized nerve fibers.
• Hirschsprung Disease: Absence of ganglion cells (aganglionosis) and presence of hypertrophic nerve trunks.

3. Contrast Enema

Contrast enema is used to visualize the anatomical features of the colon.

Procedure:

• A contrast material is introduced into the colon via the rectum, and X-ray images are taken.

Findings:

• Normal Colon: Even distribution of contrast without significant narrowing or dilation.
• Hirschsprung Disease: A transition zone is typically seen, where there is a sudden change from a narrow, aganglionic distal segment to a dilated, ganglionated proximal segment.

4. Anorectal Manometry

Anorectal manometry measures rectal and anal sphincter reflexes.

Procedure:

• A balloon catheter is inserted into the rectum, and various pressures are measured while the balloon is inflated and deflated.

Findings:

• Normal Reflexes: Presence of the rectoanal inhibitory reflex (RAIR), where the internal anal sphincter relaxes in response to rectal distension.
• Hirschsprung Disease: Absence of the RAIR, indicating a lack of reflexive relaxation of the internal anal sphincter in response to rectal distension.

5. Full-Thickness Rectal Biopsy

Full-thickness rectal biopsy is performed when the suction biopsy is inconclusive.

Procedure:

• A larger and deeper sample of the rectal wall is obtained, including mucosa, submucosa, and muscularis propria.

Findings:

• Normal Tissue: Presence of ganglion cells in all layers and normal-sized nerve fibers.
• Hirschsprung Disease: Absence of ganglion cells in all layers and presence of hypertrophic nerve trunks, confirming aganglionosis.

6. Genetic Testing

Genetic testing identifies mutations associated with Hirschsprung disease, particularly useful in familial cases.

Procedure:

• A blood sample or buccal swab is taken for DNA analysis.

Findings:

• RET Gene Mutations: Mutations in the RET proto-oncogene are the most common genetic cause of Hirschsprung disease.
• Other Genes: Mutations in EDNRB, EDN3, GDNF, and other genes may also be identified, especially in syndromic cases or familial patterns.

---

Management

Definitive Treatment:

• Surgical Resection: The primary treatment for HD involves surgical resection of the aganglionic segment and anastomosis of the normal bowel to the rectum. The surgical approach may vary based on the extent of aganglionosis.

Management Based on Types of Hirschsprung Disease:

1. Short-Segment HD:
   • Surgical Procedure: Transanal endorectal pull-through is commonly performed. This procedure involves resecting the aganglionic segment through the anus and pulling the normal bowel through to the rectum.
   • Postoperative Care: Includes monitoring for complications such as enterocolitis, strictures, and bowel function. Long-term follow-up to manage constipation and bowel control issues.
2. Long-Segment HD:
   • Surgical Procedure: Abdominal or laparoscopic-assisted pull-through procedures are often necessary due to the extensive involvement of the colon. This may involve a multi-stage approach with initial colostomy followed by definitive pull-through surgery.
   • Postoperative Care: Careful monitoring for complications such as anastomotic leakage and bowel function. Long-term management of bowel habits and nutritional status.
3. Total Colonic Aganglionosis:
   • Surgical Procedure: Requires a more complex surgical approach, often a multi-stage procedure. Initial colostomy or ileostomy is performed, followed by a definitive pull-through procedure to connect the small intestine to the rectum.
   • Postoperative Care: Intensive monitoring for complications such as small bowel bacterial overgrowth, nutritional deficiencies, and long-term bowel management strategies.

Supportive Treatment:

• Preoperative Care:
  • Bowel decompression through rectal irrigation.
  • Antibiotics to prevent/treat enterocolitis.
  • Nutritional support, especially for infants with failure to thrive.
• Postoperative Care:
  • Regular follow-up to monitor growth, bowel function, and nutritional status.
  • Management of potential complications such as enterocolitis, strictures, and constipation.
  • Education and support for families to manage bowel habits and nutritional needs.

Non-Surgical Management:

• Rectal Irrigation:
  • For patients awaiting surgery or those with ultra-short segment HD, rectal irrigation can help decompress the bowel and relieve symptoms. Regular irrigation can be an effective short-term management strategy.
• Dietary Management:
  • High-fiber diet, adequate hydration, and stool softeners may help manage constipation in mild cases or post-surgery.

Follow-Up and Prognosis

Long-Term Follow-Up:

• Regular follow-ups to monitor growth, bowel function, and nutritional status.
• Addressing any complications, including chronic constipation, fecal incontinence, and psychosocial issues.

Prognosis:

• Generally favorable with early diagnosis and appropriate surgical treatment.
• Lifelong monitoring may be necessary to manage and mitigate long-term complications.

By understanding the etiology, pathophysiology, types, clinical presentation, diagnostic tests, and management strategies for Hirschsprung disease, pediatric residents can provide comprehensive care to affected patients and improve their clinical outcomes.